The Global DNA (Deoxyribonucleic Acid) and Gene Chip Market is projected to reach $15.72 billion by 2028, from a value of $7.51 billion in 2022, by registering a CAGR of 13.1% during the forecast period. The high prevalence of cancer, increasing adoption of genetic testing, and strong presence of well-established players are the major factors propelling the growth of the market. However, the cost of microarray algorithm procedures is hampering the market growth. Moreover, increasing collaborative research activities and the growth are technological advancements in robotics are creating ample opportunities across the globe.
Recent Developments
In March 2021, Novogene expanded by opening its single-cell sequencing lab in Singapore. The new lab features a facility to provide a complete end-to-end solution of the single cell gene expression services including single-cell experimental design, single cell capture, sequencing, and data analysis.
In Nov 2020, Bio-Rad Laboratories launched Reliance Select cDNA synthesis kit to help researchers efficiently convert RNA to DNA by reverse transcription. Reliance Select cDNA Synthesis Kit is an important addition to Bio-Rads genomics portfolio, providing researchers a way to obtain highly sensitive and reproducible results.
In May 2019, MyHeritage launched the MyHeritage DNA Health+Ancestry test. The test provides a new dimension of genetic insight with comprehensive health reports that can empower future health and lifestyle choices.
In July 2019, PathogenDx, Inc. partnered with Zef Scientific in Canada. This partnership will offer Canadian growers, retailers, distributors and regulators the chance to shorten testing and approval times with greater precision, while getting better and safer products to market faster for Canadian patients and consumers.
Competitive Landscape
Thermo Fisher Scientific, Inc, Shanghai Biochip Co Ltd, Perkin Elmer, Inc., Microarrays Inc, Illumina, Inc, Greiner Bio One International GmbH, Biometrix Technology Inc, Agilent Technologies, Novogene, Bio-Rad Laboratories, MyHeritage, PathogenDx, Inc., Savyon Diagnostics, and Merck KGaA are some of the major players in the global DNA (Deoxyribonucleic Acid) and Gene Chip market.
